ID

31381

Beskrivning

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

Nyckelord

Versioner (2)
  1. 2018-07-31 2018-07-31 -
  2. 2018-08-18 2018-08-18 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

18 augusti 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593

Engelsk

Actual administered mCi Dose

1 Formulär  
Dosimetric Dose
Beskrivning

Dosimetric Dose

Alias
UMLS CUI-1
C4019308
Date dose administered
Beskrivning

Medication dose; Date in time

Datatyp

date

Alias
UMLS CUI [1,1]
C4019308
UMLS CUI [1,2]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Beskrivning

iodine-131-tositumomab; Medication dose

Datatyp

text

Måttenheter
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Therapeutic Dose
Beskrivning

Therapeutic Dose

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0178602
Date Therapeutic Dose administered
Beskrivning

Date Therapeutic Dose administered

Datatyp

date

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Beskrivning

Actual Iodine-131 Anti-B1 Antibody dose administered

Datatyp

text

Måttenheter
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Administrative
Beskrivning

Administrative

Alias
UMLS CUI-1
C1320722
Investigator Signature
Beskrivning

Investigator Signature

Datatyp

text

Alias
UMLS CUI [1]
C2346576
Date of evaluation
Beskrivning

Date of evaluation

Datatyp

date

Alias
UMLS CUI [1]
C2985720
Tillbaka till toppen

Similar models

Actual administered mCi Dose

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Dosimetric Dose
C4019308 (UMLS CUI-1)
Medication dose; Date in time
Item
Date dose administered
date
C4019308 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
iodine-131-tositumomab; Medication dose
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Therapeutic Dose
C0087111 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
Date Therapeutic Dose administered
Item
Date Therapeutic Dose administered
date
C0087111 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Actual Iodine-131 Anti-B1 Antibody dose administered
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Administrative
C1320722 (UMLS CUI-1)
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Date of evaluation
Item
Date of evaluation
date
C2985720 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial